Aydin Faruk, Cubukçu Kivanç, Yetişkul Serpil, Yazici Yelda, Kaklikkaya Neşe
Karadeniz Teknik Universitesi Tip Fakültesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali, Trabzon.
Mikrobiyol Bul. 2002 Jan;36(1):85-90.
Transfusion of blood and blood products is a widely used method for therapy in medicine, however it may result with the transmission of infectious agents from donor to recipient. In order to achieve safe blood transfusions and to minimize post-transfusion infections, several screening tests for infectious agents are routinely done all around the world as well as in our country. In this study, HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody tests results have been retrospectively evaluated for 33.766 blood donors during January 1, 1997 to December 31, 2000 in Blood Center of Farabi Hospital, Black Sea Technical University. Testing for HBsAg, anti-HIV and anti-HCV has been done by using commercially available micro and/or macro enzyme immunoassays, and syphilis reagin antibody test by latex agglutination (RPR) method. The indeterminate results were confirmed by retesting of sera with microparticle enzyme immunoassay and Western blot methods. As a result, in 1331 (3.94%) subjects HBsAg, in 250 (0.74%) subjects anti-HCV, and in 161 (0.47%) subjects RPR were found positive. Twenty samples which have had the results in gray-zone for anti-HIV, have been found negative with the confirmation tests.
输血及血液制品是医学中广泛应用的治疗方法,但它可能导致感染因子从供血者传播给受血者。为了实现安全输血并尽量减少输血后感染,世界各地以及我国都常规地对感染因子进行多项筛查检测。在本研究中,回顾性评估了1997年1月1日至2000年12月31日期间,黑海技术大学法拉比医院血库33766名献血者的乙肝表面抗原(HBsAg)、抗丙型肝炎病毒(anti-HCV)、抗人类免疫缺陷病毒(anti-HIV)和梅毒反应素抗体检测结果。HBsAg、anti-HIV和anti-HCV检测采用市售的微量和/或常量酶免疫测定法,梅毒反应素抗体检测采用乳胶凝集(RPR)法。不确定结果通过用微粒酶免疫测定法和免疫印迹法对血清进行复测来确认。结果,1331名(3.94%)受试者的HBsAg、250名(0.74%)受试者的anti-HCV以及161名(0.47%)受试者的RPR呈阳性。20份anti-HIV结果处于灰区的样本,经确认检测为阴性。